JP2021512143A5 - - Google Patents
Info
- Publication number
- JP2021512143A5 JP2021512143A5 JP2020560615A JP2020560615A JP2021512143A5 JP 2021512143 A5 JP2021512143 A5 JP 2021512143A5 JP 2020560615 A JP2020560615 A JP 2020560615A JP 2020560615 A JP2020560615 A JP 2020560615A JP 2021512143 A5 JP2021512143 A5 JP 2021512143A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- amino
- carboxamide
- acetyl
- pyridine
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023191935A JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1801355.7 | 2018-01-26 | ||
| GBGB1801355.7A GB201801355D0 (en) | 2018-01-26 | 2018-01-26 | Compounds |
| PCT/GB2019/050209 WO2019145726A1 (en) | 2018-01-26 | 2019-01-25 | Compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191935A Division JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512143A JP2021512143A (ja) | 2021-05-13 |
| JP2021512143A5 true JP2021512143A5 (https=) | 2022-02-02 |
| JPWO2019145726A5 JPWO2019145726A5 (https=) | 2022-02-02 |
Family
ID=61558141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560615A Pending JP2021512143A (ja) | 2018-01-26 | 2019-01-25 | 化合物 |
| JP2023191935A Pending JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191935A Pending JP2024023271A (ja) | 2018-01-26 | 2023-11-10 | 化合物 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US11364246B2 (https=) |
| EP (3) | EP3743406B9 (https=) |
| JP (2) | JP2021512143A (https=) |
| KR (1) | KR102827138B1 (https=) |
| CN (2) | CN119490451A (https=) |
| AU (2) | AU2019213211B2 (https=) |
| BR (1) | BR112020015169A2 (https=) |
| CA (1) | CA3086747A1 (https=) |
| CL (1) | CL2020001945A1 (https=) |
| CO (1) | CO2020010552A2 (https=) |
| CR (1) | CR20200373A (https=) |
| DK (1) | DK3743406T3 (https=) |
| EA (1) | EA202091576A1 (https=) |
| ES (1) | ES2943636T3 (https=) |
| FI (1) | FI3743406T3 (https=) |
| GB (4) | GB201801355D0 (https=) |
| HR (1) | HRP20230294T1 (https=) |
| HU (1) | HUE061394T2 (https=) |
| IL (1) | IL276034B2 (https=) |
| LT (1) | LT3743406T (https=) |
| MA (1) | MA51669B1 (https=) |
| MX (1) | MX2020007899A (https=) |
| PE (1) | PE20210657A1 (https=) |
| PH (1) | PH12020551327A1 (https=) |
| PL (1) | PL3743406T3 (https=) |
| PT (1) | PT3743406T (https=) |
| RS (1) | RS64073B1 (https=) |
| SG (1) | SG11202006067XA (https=) |
| SI (1) | SI3743406T1 (https=) |
| TW (1) | TWI908705B (https=) |
| WO (1) | WO2019145726A1 (https=) |
| ZA (1) | ZA202003856B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| PH12021553110A1 (en) * | 2019-06-12 | 2022-08-01 | Tmem16A Ltd | Compounds for treating respiratory disease |
| GB201908453D0 (en) | 2019-06-12 | 2019-07-24 | Enterprise Therapeutics Ltd | Compounds for treating respiratory disease |
| GB201910608D0 (en) * | 2019-07-24 | 2019-09-04 | Enterprise Therapeutics Ltd | Compounds |
| PE20221441A1 (es) * | 2019-07-24 | 2022-09-21 | Tmem16A Ltd | Derivados de piridina como moduladores de tmem16a para su uso en el tratamiento de afecciones respiratorias |
| GB201910665D0 (en) * | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
| GB201910664D0 (en) | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel forms of compound |
| GB201910666D0 (en) * | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
| PE20220346A1 (es) * | 2019-08-28 | 2022-03-14 | Novartis Ag | Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades |
| WO2021117767A1 (ja) * | 2019-12-10 | 2021-06-17 | 田辺三菱製薬株式会社 | 含窒素ヘテロアリールカルボキサミド酢酸誘導体の製造方法 |
| AU2021263914A1 (en) | 2020-04-29 | 2022-11-03 | D.E. Shaw Research, Llc | PI3K-α inhibitors and methods of use thereof |
| CA3189027A1 (en) | 2020-07-11 | 2022-01-20 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US20230271918A1 (en) * | 2020-08-10 | 2023-08-31 | Dana-Farber Cancer Institute, Inc. | Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| EP4259607A1 (en) | 2020-12-11 | 2023-10-18 | Tmem16A Limited | Benzimidazole derivatives for treating respiratory disease |
| US20220213041A1 (en) | 2021-01-06 | 2022-07-07 | AbbVie Global Enterprises Ltd. | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use |
| EP4274828A1 (en) | 2021-01-06 | 2023-11-15 | AbbVie Global Enterprises Ltd. | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
| CN120476113A (zh) * | 2022-12-20 | 2025-08-12 | 杭州中美华东制药有限公司 | 具有sting抑制作用的含肟化合物及其药物组合物和用途 |
| TW202527954A (zh) * | 2023-11-15 | 2025-07-16 | 美商傳達治療有限公司 | PI3Kα抑制劑及其製造與使用方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59106766D1 (de) | 1990-11-19 | 1995-11-30 | Christ Ag | Verfahren und Einrichtung zur Entsalzung von wässrigen Flüssigkeiten. |
| US6388054B1 (en) * | 1998-08-20 | 2002-05-14 | John M. Stewart | Anti-cancer compounds |
| TWI243164B (en) | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| TWI239942B (en) * | 2001-06-11 | 2005-09-21 | Dainippon Pharmaceutical Co | N-arylphenylacetamide derivative and pharmaceutical composition containing the same |
| GB0129267D0 (en) | 2001-12-06 | 2002-01-23 | Syngenta Ltd | Fungicides |
| JPWO2004011430A1 (ja) * | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
| WO2004035545A2 (en) * | 2002-10-18 | 2004-04-29 | E.I. Du Pont De Nemours And Company | Azolecarboxamide herbicides |
| WO2004106324A1 (en) * | 2003-05-27 | 2004-12-09 | E.I. Dupont De Nemours And Company | Azolecarboxamide herbicides |
| CN100545161C (zh) * | 2003-08-15 | 2009-09-30 | 中国科学院上海药物研究所 | 一类杂环衍生物、制备方法及其用途 |
| US20060069132A1 (en) * | 2004-04-07 | 2006-03-30 | Armel Gregory R | Azolecarboxamide herbicides |
| CN101180858B (zh) * | 2005-04-25 | 2012-05-30 | Lg电子株式会社 | 用于在读取器控制器与读取器之间接收并处理消息的方法 |
| US7754717B2 (en) * | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
| CA2658362A1 (en) * | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| EP2072501A1 (en) * | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Aminobenzamide derivatives as useful agents for controlling animal parasites |
| RU2529484C2 (ru) | 2008-05-05 | 2014-09-27 | Санофи-Авентис | Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств |
| BRPI0909945A2 (pt) * | 2008-06-20 | 2015-07-28 | Genentech Inc | "composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinase em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase" |
| WO2010036316A1 (en) | 2008-09-24 | 2010-04-01 | Yangbo Feng | Urea and carbamate compounds and analogs as kinase inhibitors |
| EP2184273A1 (de) * | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| KR20140105433A (ko) | 2011-09-01 | 2014-09-01 | 아이알엠 엘엘씨 | Pdgfr 키나제 억제제로서의 화합물 및 조성물 |
| US8883819B2 (en) * | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| WO2013165606A1 (en) | 2012-05-04 | 2013-11-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| WO2014181287A1 (en) | 2013-05-09 | 2014-11-13 | Piramal Enterprises Limited | Heterocyclyl compounds and uses thereof |
| US9688637B2 (en) * | 2014-08-21 | 2017-06-27 | Northwestern Universtiy | 3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members |
| ES2746839T3 (es) | 2014-12-18 | 2020-03-09 | Pfizer | Derivados de pirimidina y triazina y su uso como inhibidores de AXL |
| WO2017083971A1 (en) * | 2015-11-16 | 2017-05-26 | University Of Manitoba | Compositions and methods for treatment of influenza |
| GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| US20200361871A1 (en) | 2018-01-26 | 2020-11-19 | Enterprise Therapeutics Ltd. | Compounds |
| GB201910665D0 (en) | 2019-07-25 | 2019-09-11 | Enterprise Therapeutics Ltd | Novel form of compounds |
-
2018
- 2018-01-26 GB GBGB1801355.7A patent/GB201801355D0/en not_active Ceased
-
2019
- 2019-01-25 CN CN202411465530.3A patent/CN119490451A/zh active Pending
- 2019-01-25 PL PL19702958.0T patent/PL3743406T3/pl unknown
- 2019-01-25 CN CN201980010318.9A patent/CN111683926B/zh active Active
- 2019-01-25 HU HUE19702958A patent/HUE061394T2/hu unknown
- 2019-01-25 EP EP19702958.0A patent/EP3743406B9/en active Active
- 2019-01-25 HR HRP20230294TT patent/HRP20230294T1/hr unknown
- 2019-01-25 IL IL276034A patent/IL276034B2/en unknown
- 2019-01-25 WO PCT/GB2019/050209 patent/WO2019145726A1/en not_active Ceased
- 2019-01-25 FI FIEP19702958.0T patent/FI3743406T3/fi active
- 2019-01-25 GB GB2108469.4A patent/GB2600512A/en not_active Withdrawn
- 2019-01-25 PT PT197029580T patent/PT3743406T/pt unknown
- 2019-01-25 EP EP25202575.4A patent/EP4699655A3/en active Pending
- 2019-01-25 SI SI201930440T patent/SI3743406T1/sl unknown
- 2019-01-25 EA EA202091576A patent/EA202091576A1/ru unknown
- 2019-01-25 LT LTEPPCT/GB2019/050209T patent/LT3743406T/lt unknown
- 2019-01-25 CA CA3086747A patent/CA3086747A1/en active Pending
- 2019-01-25 CR CR20200373A patent/CR20200373A/es unknown
- 2019-01-25 KR KR1020207020956A patent/KR102827138B1/ko active Active
- 2019-01-25 GB GB2013290.8A patent/GB2583882B/en active Active
- 2019-01-25 MA MA51669A patent/MA51669B1/fr unknown
- 2019-01-25 TW TW108102837A patent/TWI908705B/zh active
- 2019-01-25 SG SG11202006067XA patent/SG11202006067XA/en unknown
- 2019-01-25 JP JP2020560615A patent/JP2021512143A/ja active Pending
- 2019-01-25 AU AU2019213211A patent/AU2019213211B2/en active Active
- 2019-01-25 BR BR112020015169-6A patent/BR112020015169A2/pt unknown
- 2019-01-25 MX MX2020007899A patent/MX2020007899A/es unknown
- 2019-01-25 RS RS20230225A patent/RS64073B1/sr unknown
- 2019-01-25 GB GBGB2105206.3A patent/GB202105206D0/en not_active Ceased
- 2019-01-25 DK DK19702958.0T patent/DK3743406T3/da active
- 2019-01-25 ES ES19702958T patent/ES2943636T3/es active Active
- 2019-01-25 EP EP22214010.5A patent/EP4215520A1/en not_active Withdrawn
- 2019-01-25 PE PE2020001115A patent/PE20210657A1/es unknown
- 2019-11-22 US US16/501,493 patent/US11364246B2/en active Active
-
2020
- 2020-06-25 ZA ZA2020/03856A patent/ZA202003856B/en unknown
- 2020-07-23 CL CL2020001945A patent/CL2020001945A1/es unknown
- 2020-08-25 PH PH12020551327A patent/PH12020551327A1/en unknown
- 2020-08-26 CO CONC2020/0010552A patent/CO2020010552A2/es unknown
-
2022
- 2022-05-17 US US17/663,716 patent/US12377105B2/en active Active
-
2023
- 2023-01-20 AU AU2023200327A patent/AU2023200327A1/en not_active Abandoned
- 2023-11-10 JP JP2023191935A patent/JP2024023271A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512143A5 (https=) | ||
| GB2583882A (en) | Compounds | |
| JPWO2019145726A5 (https=) | ||
| US10195213B2 (en) | Chemical entities that kill senescent cells for use in treating age-related disease | |
| EP1833799B1 (en) | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | |
| CN1428145A (zh) | 用作速激肽nk3受体拮抗剂的喹啉衍生物 | |
| RU2008136553A (ru) | Производные бензотиазола в качестве агонистов бета2 адренорецептора | |
| JP2013510883A5 (https=) | ||
| JP2013523636A5 (https=) | ||
| JP2016514711A5 (https=) | ||
| CA2618511A1 (en) | Novel benzothiazolone derivatives | |
| NL1028599C2 (nl) | Verbindingen voor de behandeling van ziekten. | |
| JPWO2021062245A5 (https=) | ||
| RU2015114937A (ru) | Замещенные соединения карбамата и их применение в качестве антагонистов канала с транзиторным рецепторным потенциалом (trp) | |
| MXPA05003105A (es) | Compuestos de amonio cuaternario. | |
| JPWO2019220147A5 (https=) | ||
| CN120435316A (zh) | 包括金属通道激活剂和nmda受体拮抗剂的组合疗法 | |
| JP2025500346A (ja) | 睡眠時無呼吸の治療のためのα２－アドレナリン受容体サブタイプＣ（アルファ－２Ｃ）アンタゴニストとムスカリン受容体アンタゴニストとの組合せ | |
| JPWO2021014172A5 (https=) | ||
| JPWO2023150291A5 (https=) | ||
| WO2024054807A1 (en) | Combination therapies including metal channel activators and tdp-43 modulators | |
| JPWO2021014166A5 (https=) | ||
| KR20240124995A (ko) | 수면 무호흡의 치료를 위한 a2-아드레날린수용체 하위유형 c (알파-2c) 길항제와 노르에피네프린 재흡수 억제제의 조합물 | |
| EA046966B1 (ru) | Соединения | |
| HK1118552A (en) | 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |